(Q41294180)

29 September 2017

Bone cells and bone turnover in diabetes mellitus (English)

1 reference

29 September 2017

Mishaela R Rubin

1

1 reference

PubMed ID

25740570

29 September 2017

language of work or name

1 reference

1 June 2015

1 reference

Current osteoporosis reports

29 September 2017

1 reference

29 September 2017

13

1 reference

29 September 2017

3

1 reference

29 September 2017

186-191

1 reference

https://scigraph.springernature.com/pub.10.1007/s11914-015-0265-0

29 September 2017

0 references

cites work

Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

FRAX underestimates fracture risk in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Predictors of outcome following hip fracture rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

A national perspective of Medicare expenditures for elderly veterans with hip fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Association between bone mineral density and type 1 diabetes mellitus: a meta-analysis of cross-sectional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Octreotide abolishes the acute decrease in bone turnover in response to oral glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Understanding the skeletal pathology of type 1 and 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Bone metabolic abnormalities associated with well-controlled type 1 diabetes (IDDM) in young adult women: a disease complication often ignored or neglected.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Circulating osteogenic precursor cells in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Characterization of circulating osteoblast lineage cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Circulating sclerostin associated with vertebral bone marrow fat in older men but not women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

The role of the collagen matrix in skeletal fragility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Accelerated age-related browning of human collagen in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Diabetes Mellitus: Does it Affect Bone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Nonenzymatic glycation of collagen in aging and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Pentosidine effects on human osteoblasts in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Pentosidine and increased fracture risk in older adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Stiffness of compact bone: effects of porosity and density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

A bone structural basis for fracture risk in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Biphasic fracture risk in diabetes: A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-015-0265-0

Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus.

21 January 2018

1 reference

12 December 2020

Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus

1 reference

12 December 2020

Bone loss and bone turnover in diabetes

1 reference

12 December 2020

Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes

1 reference

12 December 2020

Older women with diabetes have an increased risk of fracture: a prospective study

1 reference

12 December 2020

Hypocalcemia and parathyroid hormone responsiveness in diabetes mellitus: a tri-sodium-citrate clamp study

1 reference

12 December 2020

Risk of Fracture in Women with Type 2 Diabetes: the Women’s Health Initiative Observational Study

1 reference

12 December 2020

Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk

1 reference

12 December 2020

Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes

1 reference

12 December 2020

Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally

1 reference

12 December 2020

10.1007/S11914-015-0265-0

Identifiers

DOI

1 reference

29 September 2017

1 reference

PubMed ID

25740570